Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jun;9(2):331-339.
doi: 10.1002/iid3.404. Epub 2021 Feb 10.

Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19

Affiliations
Review

Age-related differences in the immune response could contribute to determine the spectrum of severity of COVID-19

Giorgio Costagliola et al. Immun Inflamm Dis. 2021 Jun.

Abstract

Coronavirus disease 2019 (COVID-19), can present with a wide spectrum of severity. Elderly patients with cardiac, pulmonary and metabolic comorbidities are more likely to develop the severe manifestations of COVID-19, which are observed in less than 5% of the pediatric patients. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is able to induce an immune impairment and dysregulation, finally resulting in the massive release of inflammatory mediators, strongly contributing to the pulmonary and systemic manifestations in COVID-19. In children, the immune dysregulation following SARS-CoV-2 can also be responsible of a severe disease phenotype defined as multisystem inflammatory syndrome in children. As the immune system undergoes a complex process of maturation from birth to adult age, differences in the immune and inflammatory response could have a significant impact in determining the spectrum of severity of COVID-19. Indeed, children show a higher ability to respond to viral infections and a reduced baseline pro-inflammatory state compared with elderly patients. Age and comorbidities contribute to disease severity through immune-mediated mechanisms, since they are associated with a chronic increase of pro-inflammatory mediators, and cause an enhanced susceptibility to develop an immune dysregulation following SARS-CoV-2 infection. Also the expression of ACE2, the receptor of SARS-CoV-2, varies with age, and is linked to the immune and inflammatory response through a complex, and not completely elucidated, network. This paper reviews the peculiar immunopathogenic aspects of COVID-19, with a focus on the differences between adult and pediatric patients.

Keywords: ACE2; children; coronavirus; cytokine storm; immune dysregulation; multisystem inflammatory syndrome in children (MIS-C).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interests.

Figures

Figure 1
Figure 1
Pathogenic model of severe COVID‐19. The left side of the figure shows the activation of innate and adaptive immune response following viral infection. The right side analyzes how impaired immunity, immune dysregulation, and uncontrolled inflammation led to massive tissue damage, thus enhancing the inflammatory response, finally leading to ARDS, septic shock and MOF. ARDS, acute respiratory distress syndrome; MOF, multiorgan failure

Similar articles

Cited by

References

    1. Rodriguez‐Morales AJ, Cardona‐Ospina JA, Gutiérrez‐Ocampo E, et al. Clinical, laboratory and imaging features of COVID‐19: a systematic review and meta‐analysis. Travel Med Infect Dis. 2020;34:101623. - PMC - PubMed
    1. Sarzi‐Puttini P, Giorgi V, Sirotti S, et al. COVID‐19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020;38(2):337‐342. - PubMed
    1. Zheng Z, Peng F, Xu B, et al. Risk factors of critical & mortal COVID‐19 cases: a systematic literature review and meta‐analysis. J Infect. 2020;81(2):e16‐e25. - PMC - PubMed
    1. Yang J, Hu J, Zhu C. Obesity aggravates COVID‐19: a systematic review and meta‐analysis. J Med Virol. 2020:jmv.26677 - PMC - PubMed
    1. Liguoro I, Pilotto C, Bonanni M, et al. SARS‐COV‐2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020;179(7):1029‐1046. - PMC - PubMed

MeSH terms

Supplementary concepts